-
Dual Effect Combination: Phase I Study SuccessfulMar 14, 2026Eli Lilly tshaj tawm qhov kev vam meej Phase I kawm txog kev sib xyaw ntawm Tirzepatide thiab Yiqizhu monoclonal antibody Thaum Lub Ob Hlis 18, 202...
-
GLP-1/GIP Dual Bias: Evolution Of Long-acting FormulationsMar 08, 2026Thaum Lub Ob Hlis 16, 2026, Shiyao Group tshaj tawm tias nws GLP-1/GIP receptor dual directional agonist peptide ntev-kev txhaj tshuaj (SYH2082 txh...
-
Brazil Cov Neeg Siv Khoom Andre tau xaj ntau dua 30 yam khoom sib txawv ntawm Peptides los ntawm ...Feb 12, 2026Brazil Cov Neeg Siv Khoom Andre tau xaj ntau dua 30 yam khoom sib txawv ntawm Peptides los ntawm BLOOM TECH. (tag nrho tshaj $12,300) thiab tau tsi...
-
Lub teb chaws Yelemees --- Yuav 16 Lub thawv PeptidesFeb 11, 2026Nyob rau niaj hnub no lub sij hawm ntawm kev loj hlob sai biotechnology, cov kws tshawb fawb txuas ntxiv mus unravel lub mysteries ntawm lub neej n...
-
Teb Chaws Asmeskas Cov Neeg Siv Khoom --- Yuav Retatrutide 30mgFeb 11, 2026Hauv kev kho mob rog rog thiab cov kab mob metabolic, Retatrutide - lub ntiaj teb thawj triple hormone receptor agonist - tau txais kev saib xyuas ...
-
Thaib Cov Neeg Siv Khoom Wanissa Yuav Tirzepatide Los ntawm BLOOM TECHFeb 10, 2026Thai peptide cov neeg siv khoom Wanissa yuav plaub lub thawv qauv ntawm BLOOM TECH's Tirzepatide 20mg los ntawm tus neeg muag khoom. Nws zoo siab t...
-
UK Cov Neeg Siv Khoom Sean Yuav BLOOM TECH GS441524 ntsiav tshuajFeb 07, 2026Bloom Tech, raws li cov chaw tsim khoom tshwj xeeb hauv cov khoom siv raw thiab kev ua haujlwm, muaj GS441524 hauv ntau hom nrog rau kev txhaj tshu...
-
Activet Pharma's Chr Olesen tab tom yuav Cov Khoom Siv Tshuaj Ua Haujlwm: GS-441524Feb 05, 2026Thaum lub sij hawm kev yuav khoom ntawm GS-441524 raw cov ntaub ntawv los ntawm Activet Pharma Chr Olesen, txhawm rau kom ua raws li cov txheej txh...
-
GLP-1 Agonist: Dual Effect, Reshaping Metabolic Therapy PathwayFeb 14, 2026Roche GLP-1R / GIPR agonist pib qhov kev sim tshuaj rau theem III Thaum Lub Ib Hlis 20, 2026, raws li US Clinical Trial Registry lub vev xaib, Roch...
-
GLP-1 Agonist: Dual Effect Combination, Restructuring Metabolic TherapyFeb 07, 2026Tsis ntev los no, Suzhou Ruibo Biotechnology Co., Ltd. (Tshuag code: 06938. HK), ib tug ua lag luam nyob rau hauv me me nucleic acid tshuaj, offici...
-
Nyob Zoo Xyoo Tshiab Xyoo Ntawm Nees 2026!!!Jan 29, 2026Nyob zoo cov phooj ywg, Nyob zoo Xyoo Tshiab Suav Nees 2026!!! Peb yuav raug kaw rau 10 hnub txij Lub Ob Hlis 14 txog rau Lub Ob Hlis 23. Kev lag l...
-
Australian cov neeg muas zaub tau rov yuav Peptides ua ntej Suav Xyoo Tshiab.Jan 25, 2026Thaum lub caij ntuj no txias ntawm Lub Ib Hlis 2026, peb lub sijhawm ntev -tus neeg Australian sawv cev tau muab lwm qhov kev txiav txim tseem ceeb...








